This article has Open Peer Review reports available.
Methanol extract of Melastoma malabathricum leaves exerted antioxidant and liver protective activity in rats
© Mamat et al.; licensee BioMed Central Ltd. 2013
Received: 3 May 2013
Accepted: 18 November 2013
Published: 23 November 2013
Melastoma malabathricum L. (Melastomaceae) is a small shrub with various medicinal uses. The present study was carried out to determine the hepatoprotective activity of methanol extract of M. malabathricum leaves (MEMM) against the paracetamol-induced liver toxicity in rats model.
The respective chemicals and herbal solutions (10% DMSO, 200 mg/kg silymarin or MEMM (50, 250 and 500 mg/kg)) were administered orally to rats once everyday for 7 days followed by the hepatotoxicity assay. The blood samples and livers were collected and subjected to biochemical and microscopical analysis. Prior to the hepatoprotective study, MEMM was subjected to determination of the total phenolic content (TPC) and the antioxidant properties using several standard assays (e.g. 2, 2-diphenyl-1-picrylhydrazyl- and superoxide anion- radical scavenging assay, and oxygen radical absorbance capacity assay).
MEMM exerted significant (p < 0.05) and high antioxidant activity in which high TPC was recorded; while in the hepatotoxicity study, the extract exhibited significant hepatoprotective effects against the paracetamol-induced hepatotoxic model. The results observed for serum liver enzymes (ALT, ALP and AST) as well as the microscopic observations and microscopic scoring supported the hepatoprotective potential of MEMM. The phytochemical and HPLC analysis of MEMM demonstrated the presence of flavonoids as its major constituents.
The MEMM-induced hepatoprotective activity could be allied partly to its antioxidant activity and the presence of flavonoids.
Liver is the largest organ in the human body and is a key organ of metabolism [1, 2]. Despite its considerable regenerative capacity, continuous and various exposures to xenobiotics, environmental pollutants, and chemotherapeutic agents could suppress and possibly overcome the natural protective mechanisms of the liver, leading to liver malfunction and later if it is not treated properly leads to injury. Despite the remarkable progresses in conventional medical therapies in the last 20 years, drugs available for the treatment of liver diseases were often limited in efficacy and could have triggered various unwanted side effects when compared to other medical therapies for liver diseases which were often difficult to handle . Moreover, some of these modern hepatoprotective drugs did not offer protection against injury to the vital organ despite their direct or indirect action to improve the liver function. In response to these factors that limit the use of conventional drugs, attempts were continuously made by scientists all over the world working in the area of hepatoprotective drug discovery to identify new sources of agents with potential liver protective activity [4, 5].
Interestingly, in line with increase in patients attempt to use complementary and alternative medicines, particularly herbal/plant-based therapies, to cure various diseases, efforts are increasingly being carried out by scientists to investigate the hepatoprotective potential of various medicinal plants. One of the medicinal plants that have been widely used in the Malay traditional medicine is Melastoma malabathricum L., which is locally known as “Senduduk”. This small shrub belongs to the family Melastomaceae and is native to tropical and temperate Asia, including Malaysia, and the Pacific Islands. Despite being a well-known herb in Malaysia wherein its leaves, shoots and roots are prepared in various ways to treat various types of diseases (i.e. to treat cuts or wounds, puerperal infections, high blood pressure, diabetes, dysentery, diarrhea, piles, leucorrhea, epilepsy, ulcers, gastric ulcers, scar, skin diseases, pimple and black spot at skin, hemorrhoidal bleeding, rheumatism, arthritis, prolonged fever, cancer and tenderness in the legs, to stop bleeding, to prevent scarring from smallpox, and to relieve a toothache), attempts to scientifically investigate and confirm those claims are however lacking . Scientifically, various types of extracts from different parts of M. malabathricum have been prepared and tested using a variety of in vitro and in vivo test models. The plant has been reported to possess various types of pharmacological activities (i.e. antibacterial, antiviral, antiparasitic, cytotoxicity, anticoagulant, platelet-activating factor inhibitory, wound healing, antiulcer, antidiarrheal, antivenom, anti-inflammatory, antinociceptive and antipyretic) at different doses or concentrations .
Various phytochemical constituents have been isolated and identified from various parts and extracts of M. malabathricum. Focusing, particularly, on the leaves, several bioactive compounds have been identified from different types of extracts, namely: i) 70% acetone extract – isoquercitrin 6″-O-gallate, malabathrin-A, -B, -C, -D, -E and -F, 1,4,6-tri-O- galloyl-β-D-glucoside, 1,2,4,6-tetra-O- galloyl-β-D-glucoside, strictinin, casuarictin, pedunculagin, nobotanin-B, -D, -G, -H and -J, pterocarinin C, new complex tannins in which an ellagitannin and a flavan-3-ol are bound by a C-glycosidic linkage belonging to type II + tannins, casuarinin, (−)-epicatechin gallate, (−)-epicatechin, stachyurin, procyanidin-B2 and -B5, stenophyllanins A and B, alienanin B, and brevifolincarboxylic acid; ii) methanol extract – ursolic acid, 2-hydroxyursolic acid and asiatic acid, as well as glycerol-1,2-dilinolenyl-3-O-β-Dgalactopyranoside and glycerol 1,2-dilinolenyl-3-O- (4,6-di-O- isopropylidene)-β-D-galactopyranoside, 2,5,6-trihydroxynaphtoic carbonic acid, methyl-2,5,6-trihydroxynaphtalene carbonate, flavonol glycoside derivative, quercitrin and kaempferol-3-O-(2′,6′-di-O-p-trans-coumaroyl)-β-glucoside; iii) hexane fraction of methanol extract – β-sitosterol, α-amyrin, uvaol, quercetin, quercitrin, rutin, and sitosterol-3-O-β-D-glucopyranoside; iv) 90% aqueous methanolic extract – ursolic acid, 2α-hydroxyursolic acid and asiatic acid, β-sitosterol 3- O-β-Dglucopyranoside, glycerol 1,2-dilinolenyl-3-O-β-D-galactopyranoside and glycerol 1,2-dilinolenyl-3-O-(4,6-O- isopropylidene)-β-D-galactopyranoside; v) ethyl acetate extract – 2,5,6-trihydroxynaphtoic carbonic acid, methyl-2,5,6-trihydroxynaphtalene carbonate, and flavonol glycoside derivative, quercetin and quercitrin; and vi) hexane extract – 2,5,6-trihydroxynaphtoic carbonic acid, methyl-2,5,6-trihydroxynaphtalene carbonate, and flavonol glycoside derivative, α-amyrin, patriscabatrine and auranamide.
Based on the previously demonstrated anti-inflammatory activity of M. malabathricum and the reports relating, at least, the anti-inflammatory and antioxidant activities to the hepatoprotective mechanism [9–11], the present study was carried out with an attempt to explore the antioxidant and hepatoprotective activities of M. malabathricum. It is postulated that M. malabathricum leaves extract, which possesses the anti-inflammatory activities, will also exert antioxidant and hepatoprotective activities. Therefore, the aim of the present study was to determine the hepatoprotective activity of methanol extract of M. malabathricum (MEMM) using the paracetamol-induced liver damage in rats as the animal model. In addition, the antioxidant activity, phytochemical content and HPLC profile of MEMM were also verified to support the hepatoprotective potential of the extract.
Collection of plant material
The leaves of M. malabathricum were continuously collected from their natural habitat in Serdang, Selangor, Malaysia between September 2011-Jun 2012 and identified by comparison with specimens available at the Herbarium of the Laboratory of Natural Products, IBS, UPM, Serdang, Selangor, Malaysia. Sample of the plant was also deposited at the same herbarium (voucher specimen, ACP 0017).
Preparation of plant extract
The plant extraction procedure was carried out according to the previously described method . Briefly, the leaves were dried under shade at room temperature for at least 7 days, segregated, and pulverized by mechanical grinder to form coarse powder. The coarse powder of air-dried leaves was subjected to methanol extraction whereby 40 g of powder leaves were macerated in 800 ml of methanol for 72 hours in the ratio of 1:20 (w/v). The methanol supernatant obtained was filtered sequentially using cloth filter, cotton wool and Whatman No. 1 filter paper, collected and then evaporated until dryness under reduced pressure (204 mbar) at the temperature of 40°C (Buchi Rotavapor® R210/215, Switzerland). On the other hand, the residue was also collected and subjected to the similar extraction and evaporation processes for another two times . At the end of the evaporation process, the amount of crude dried MEMM obtained was 7.45 g and the percentage of yield was approximately 18.6%.
Paracetamol, silymarin, nitroblue tetrazolium salt (NBT), phenazine methosulfate (PMS), 2,2′-azobis (2-amidinopropane) dihydrochloride (AAPH), Trolox (6-hydroxy-2, 5, 7, 8-tetramethylchroman-2-carboxylic acid), a water-soluble analog of vitamin E, and β-phycoerithrin, were purchased from Sigma-Aldrich Co. (St. Louis, MO, USA) and used in the present study. All other chemicals and reagents used were of analytical grade.
Male Sprague Dawley rats (180–200 g; 8–10 weeks old) and male ICR mice (25–30 g; 5–7 weeks old) were obtained from the Veterinary Animal Unit, Faculty of Veterinary Medicine, Universiti Putra Malaysia (UPM), Malaysia and kept under room temperature (27 ± 2°C; 70 – 80% humidity; 12 h light/dark cycle) in the Animal Holding Unit (UPM). They were supplied with food and water ad libitum from the beginning of the experiments. The study protocol of the present study was approved by the Animal House and Use Committee, Faculty of Medicine and Health Sciences, UPM (Ethical approval no.: UPM/FPSK/PADS/BR-UUH/00449). The rats were handled in accordance with current UPM guidelines for the care of laboratory animals and the ethical guidelines for investigations of experimental pain in conscious animals. All experiments were conducted between 09.30 and 18.30 h to minimize the effects of environmental changes.
Pharmacological studies of MEMM
Antioxidant activity of MEMM
In an attempt to determine the antioxidant potential of MEMM, the total phenolic content (TPC), 2, 2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity, superoxide anion radical scavenging and oxygen radical absorbance capacity (ORAC) of MEMM was determined according to the respective method of [13–16] but with slight modifications. Detailed procedures for TPC and DPPH assays were as reported by Zakaria et al. .
Superoxide anion radical scavenging
where A0 was the absorbance of the control (L-ascorbic acid), and A1 was the absorbance in the presence of MEMM or standards.
Oxygen radical absorbance capacity (ORAC)
Hepatoprotective activity of MEMM
The hepatoprotective activity of MEMM was determined using paracetamol-induced hepatotoxicity model, of which rats were used . The animals were fasted for 48 hours prior to the experiment but allowed access to distilled water (dH2O) ad libitum under standard laboratory conditions. After 48 hours, each group of rats (Group II-VI; n = 6) received the respective dose of chemical (10% DMSO) or herbal (200 mg/kg silymarin or 50, 250 or 500 mg/kg MEMM) solutions orally once daily for 7 consecutive days. The doses of MEMM were selected based on the single dose (5000 mg/kg) acute toxicity study performed in the previous studies. The MEMM did not cause any signs of toxicity at the dose of 5000 mg/kg according to the results shown by all the blood parameters and serum biochemical analysis. However, this dose was found to cause significant reduction of the rats’ body weight. Therefore, the doses range of MEMM (50, 250, 500 mg/kg) used in the present study was selected based on the 100, 20 and 10 folds reduction of the dose 5000 mg/kg used in the toxicity study. The oral administration of paracetamol was performed 3 hours after the administration of the last chemical or herbal solutions on the 7th day. As for Group I, the rats were pretreated with 10% DMSO for 7 consecutive days followed by the administration of 10% DMSO on the 7th day. The animals were divided into 6 groups and treated with chemical or herbal (DMSO, silymarin or MEMM) solutions as described below.
Group I received 10% DMSO + 10% DMSO.
Group II received 10% DMSO + paracetamol.
Group III received 200 mg/kg silymarin + paracetamol
Group IV received 50 mg/kg MEMM + paracetamol,
Group V received 250 mg/kg MEMM + paracetamol and;
Group VI received 500 mg/kg MEMM + paracetamol.
Forty eight (48) hours after the procedure induced hepatic injury, the animals were anesthetized using diethyl ether and the blood was withdrawn for biochemical analysis. The animals were then sacrificed by cervical dislocation and the liver was removed for histopathological studies according to previously published method .
Biochemical analysis of the liver serum enzymes level
Biochemical parameters were assayed according to the standard methods as described by Yahya et al. . The alanine aminotransferase (ALT), alkaline phosphate (ALP), aspartate aminotransferase (AST) serum level were measured using the Hitachi 902 Automatic Chemical Analyser.
Histopathology investigation of the liver tissue pretreated and untreated with MEMM
The liver tissue was dissected and processed according to the method of El-Beshbishy et al.  but with slight modifications. The liver tissue which was dissected out was subsequently fixed in the 10% formalin, dehydrated in gradual ethanol (50-100%), cleared in xylene and embedded in paraffin wax. The sections, which are 5–6 μm thick, were then prepared using rotary microtome (Leica RM 2125 RTS, Singapore) and stained with hematoxylin and eosin dye for microscopic observation of histopathological changes in the liver. Liver sections were scored and evaluated according to the severity of the hepatic injury as described by El-Beshbishy et al. .
Phytochemical screening and HPLC profiling of MEMM
Phytochemical screening of the MEMM
The phytochemical screening of MEMM was performed according to the standard screening tests as adopted by Zakaria et al. . The respective test, performed to detect alkaloids, flavonoids, triterpenes, tannins, saponins and steroids, was carried out based on 5.0 g of dried powder material and 100 mg of extract (organic) as given below.
Samples were soaked in chloroform followed by addition of ammoniacal chloroform. The mixture was then treated with sulphuric acid 10% and further tested with Mayer’s reagent. Formation of white precipitates indicates the presence of alkaloids.
The methanolic extract of samples were dissolved in ether and shaken in 10% ammonia solution. Formation of yellow colour in ammonia layer indicates the presence of flavonoids.
The methanolic extract of sample was analysed using Liebermann-Buchard reagent. The extract was mixed with few drops of acetic anhydride, boiled and cooled. Concentrated sulphuric acid was then added from the sides of the test tube and observed for the formation of a brown ring at the junction of two layers. Green coloration of the upper layer and the formation of deep red color in the lower layer would indicate a positive test for steroids and triterpenoids, respectively.
Tannins and polyphenolic compounds test
The methanolic extract of samples was mixed with 1% ferric solution. Formation of blue black colour indicates the presence of hydrolysable tannins, while brownish-green indicates that of condensed tannins.
The methanolic extract of samples was mixed with distilled water in a test tube. Formation of stable froth for at least 15 minutes indicates the presence of saponins.
HPLC profiling of the MEMM
The HPLC profiling of MEMM was carried out according to the methods described by Zakaria et al.  with slight modifications. Approximately 10 mg of MEMM was dissolved in 1 ml methanol. The solution was filtered through the membrane filter (pore size 0.45 μm) prior to analysis. HPLC profiling of the extract was carried out at the Laboratory of Phytomedicine, Forest Research Institute of Malaysia, Kepong, Malaysia. A Waters Delta 600 with 600 Controller and Waters 2996 Photodiode Array (Milford, MA, USA) equipped with an autosampler, online degasser and column heater was used for HPLC analysis. Data was analysed and processed using the installed Millenium 32 Software (Waters Product). The samples were separated at 27°C on a minibore Phenomenex Luna 5 μm C18 column with dimensions 250 x 4.60 mm using a one-step linear gradient. The solvents were (A) 0.1% aqueous formic acid and (B) acetonitrile and the elution system was as follows: Initial conditions were 85% A and 15% B with a linear gradient reaching 25% B at t = 12 min. This was maintained for 10 min after which the programme returned to the initial solvent composition at t = 25 min and continued for 10 min. The flow rate used was 1.0 ml/min and the injection volume was 10 μl. The HPLC was set at 254 and 336 nm.
Identification of flavonoids in MEMM via HPLC analysis
In an attempt to identify the bioactive compound(s) present in MEMM, several standard flavonoids (i.e. quercetin, quercitrin and rutin) were injected into the HPLC system either alone or in combination with MEMM. The selection of flavonoid-based compounds was based on the range of wavelength of each peak obtained earlier.
Data obtained are presented in mean ± standard error of mean (SEM). The data were analysed using the one-way analysis of variance (ANOVA) and the differences between the groups were determined using the Dunnet post hoc test with P < 0.05 as the limit of significance.
Antioxidant activity of MEMM
The antioxidant profile and TPC value of MEMM, at the concentration of 200 μg/ml, as assessed using various oxidative assays
DPPH radical scavenging (%)
Superoxide radical scavenging (%)
TPC (mg/100 g GAE)
ORAC (μM TE/100 g)
Sample concentration (μg/ml)
Ascorbic acid (AA) 200 μg/ml
Superoxide dismutase (SOD) 6X10 -3 U/ml
Gallic acid (GAE) standard curve
Trolox standard curve
99.1 ± 0.5h
97.3 ± 0.3 h
2610.7 ± 16.5
27, 662.0 ± 377.56
In vivo hepatoprotective study
Effect of MEMM on the body weight and liver weights after induction with paracetamol
Effect of MEMM on the body and liver weights following treatment of rats against paracetamol
Body weight (BW) (g)
Liver weight (LW) (g)
211.0 ± 2.7
5.9 ± 0.3
2.9 ± 0.1
10% DMSO + Paracetamol
207.9 ± 3.6
8.7 ± 0.3a
4.9 ± 0.4a
Silymarin + Paracetamol
202.1 ± 2.6
6.9 ± 0.2ab
3.6 ± 0.1ab
MEMM + Paracetamol
203.5 ± 5.4
8.9 ± 0.2a
4.4 ± 0.1a
193.6 ± 4.1ab
7.7 ± 0.1ab
4.6 ± 0.1a
180.1 ± 3.9ab
6.2 ± 0.9b
3.8 ± 0.2ab
Macroscopic and microscopic study of the paracetamol-induced toxic liver with and without pretreatment with MEMM
Histopathological scoring of the paracetamol-induced liver injury pre-treated with various doses of MEMM in rats
10% DMSO + Paracetamol
Silymarin + Paracetamol
MEMM + Paracetamol
Findings on liver serum enzymes level
Effect of paracetamol and protective treatments at ALT, AST and ALP (U/L)
15.8 ± 2.9
95.1 ± 5.9
115.6 ± 7.0
10% DMSO + Paracetamol
1714.0 ± 142.2a
2266.0 ± 140.4a
345.8 ± 39.3a
Silymarin + Paracetamol
693.4 ± 162.5ab
651.2 ± 141.1ab
190.0 ± 9.6ab
MEMM + Paracetamol
1453.0 ± 125.9a
2200.7 ± 247.0a
384.0 ± 43.8a
1308.0 ± 184.1ab
1719.0 ± 160.7ab
217.2 ± 17.2ab
979.5 ± 174.0ab
1458.0 ± 271.2ab
178.2 ± 33.9ab
Phytochemical constituents of MEMM in comparison to its dried leaves and its HPLC profile
Pyhtochemical constituents of MEMM
Phytochemical screening of M. malabathricum leaves in powder form and MEMM
Class of compound
HPLC profile of MEMM
Identfication of flavonoids in MEMM via HPLC analysis
Based on the range of wavelength of each peak obtained following HPLC analysis of MEMM, several standard flavonoids, namely quercetin, quercitrin and rutin, were selected and used in the HPLC analysis in an effort to identify the bioactive compound(s) presence in the extract. Interestingly, the MEMM was found to contain quercetin, quercitrin and rutin (Figure 3C).
Paracetamol-induced liver injury model is a conventional model used to investigate the hepatoprotective activity of extracts/compounds . In the present study, paracetamol (3 g/kg)) increased the liver weight and liver/body weight ratio of rats as previously reported and, upon biochemical analysis of the blood samples, increased ALT, ALP and AST, the liver enzymes in the serum. Histopathological observation of paracetamol-treated liver tissues revealed severe destruction of the liver normal architecture accompanied by reduction in the number of viable cells. Other observations include massive necrotic cells around the centrilobular zone expanding to parenchymal zone, which is distinguished by pyknosis and karyolysis nuclear.
Various mechanisms may be linked to the damage of the liver by different toxins. For examples, the CCl4 is transformed by the cytochrome P450 system to produce highly reactive trichloromethyl free radicals whereas upon the administration of high dose of paracetamol, the sulfation and glucuronodation routes become saturated causing the high percentage of paracetamol molecules to be oxidized to highly reactive N-acetyl-p-benzoquinone imine (NAPQI) . NAPQI, in particular, binds covalently to hepatocellular macromolecules [21, 22] that lead to activation of several biochemical processes (e.g. oxidative stress and glutathione (GSH) depletion) resulting in hepatotoxic effect . NAPQI also acts on DNA, proteins, cellular proteins causing the dysfunction and death of hepatocytes that leads to liver necrosis . Moreover, NAPQI bind to GSH to form conjugates, which will oxidize and convert GSH to glutathione disulfide (GSSG). This, in turn, reduces the GSH level in blood and liver . The depletion of GSH level in blood and liver triggers the mitochondrial dysfunction, increase of lipid peroxidation and, lastly, development of acute hepatic necrosis. The necrotized hepatic parechymal usually releases pool of several enzymes, such as AST and ALT into the circulation  that is regarded as specific enzyme for detection of liver abnormalities [27, 28]. Moreover, AST is also considered as an essential marker as it is susceptible to mitochondrial deformation primarily in zone 3, centrilobular zone [27, 28].
The present study demonstrated the ability of MEMM to exert hepatoprotective activity and supported our earlier hypothesis that the extract possessed anti-inflammatory, antioxidant activities and also hepatoprotective effects. The hepatoprotective potential of MEMM was further supported by the ability of the extract to reduce the serum liver enzymes (ALT and AST) level and the liver/body weight ratio, and the histopathological findings. However, through this study also the consumption of MEMM for 7 days was found to reduce the body weight of rats. This finding is in accordance with previous studies by Shimoda et al.  and Auvichayapat et al. , who reported on the presence of extracts such as green tea extract or green bean coffee extract, that reduced body weight of rats, respectively. Although the exact compound(s) that caused the suppression of rats’ body weight was not yet determined and not part of the objective of the present study, the presence of high polyphenolic compounds as well as flavonoids in MEMM  is suggested to play a significant role based on previous report by Yang et al.  and Pichiah et al. . According to Shimoda et al.  the body weight loss effect is usually seen with extracts containing high polyphenols (i.e. green tea extract and coffee). Previous study demonstrated that that modest weight loss, which is approximately 5-10% of the initial body weight, is correlated with marked advancements in various risk factors . The ability of MEMM to trigger a body weight loss effect as seen in the present study is suggested to cause no adverse effect to the body because MEMM considerably prevented the increase in body weight of approximately 10%. Since MEMM is a crude extract containing several types of compounds, including quercetin, quercitrin and rutin, it is also plausible to propose that the ability to reduce rats’ body weight involves synergistic action of those compounds as reported by Yang et al. .
Lately, much interest has been given towards the possible involvement of oxidative stress in the initiation and/or progression of paracetamol-induced hepatotoxicity. Reactive oxygen and nitrogen intermediates, generated by hepatic paranchymal and non-paranchymal cells are thought to play important roles that lead to paracetamol-induced injury [34–36]. Therefore, any compounds with high antioxidant capability are potential candidate for further development as hepatoprotective agents. Of various potential candidates, plants have been prominent source of either new or known extracts and bioactive compounds with diverse pharmacological activities. Plants have been reported to exert antioxidant activity whereas antioxidant activity has been suggested as the possible mechanism responsible for the protection against paracetamol-induced liver injury. Interestingly, our hypothesis is in accordance with report made by Gupta et al.  that the combination of hepatoprotective and antioxidant activities synergistically exerts the processes of initiation and progress of hepatocellular damage. In the present study, the MEMM has been shown to possess a high antioxidant effect through the DPPH- and superoxide anion- radical scavenging, and ORAC assays. Moreover, the extract also contained a very high TPC value wherein several reports have demonstrated the correlation between the high TPC value and the high antioxidant potential [38, 39]. Therefore, it is plausible to suggest that the mechanism of hepatoprotection exhibited by MEMM may, in part, include its ability to self-act as a free radical scavenger that might intercept those free radicals involved in paracetamol metabolism by the microsomal enzymes . Therefore, by ensnaring oxygen related radicals the MEMM could hamper their interaction with polyester fatty acids and would eliminate the enhancement of lipids peroxidative processes leading to MDA formation [36–39]. With regards to the contribution of the bioactive compounds towards the observed antioxidant activity of MEMM, the involvement of quercetin, quercitrin and rutin are worth mentioning based on previous reports [40–42].
Other than the oxidation processes, the inflammatory processes have been thought to be intimately involved in the chemical-induced hepatotoxic processes . The inflammatory processes activated by toxic agents like PCM produce various mediators, which are involved in the production of ROS and NO that can affect liver damage or repair. Therefore, it is likely to propose that the extracts/compounds exerting an anti-inflammatory activity may also show hepatoprotective activity. Based on the histological observations and scoring of the hepatotoxic liver, pre-treatment with MEMM reduced the appearance of inflammation suggesting the involvement of anti-inflammatory mechanism [6, 44]. The potential of the bioactive compounds in the anti-inflammatory activity of MEMM could be contributed by quercetin, quercitrin and rutin, in accordance with previous reports [45–47].
Phytochemical constituents have been known to play important role in determining the pharmacological potentials of various medicinal plants. Various types of bioactive compounds have been isolated, identified and scientifically proven to possess certain types of pharmacological activities from various types of plants. In term of the MEMM, flavonoids, tannins, saponins and steroids have been identified in the extract, which has also been reported to possess high TPC value . The presence of flavonoids and tannins , triterpenoids and flavonoids [49, 50], flavonol , flavonoids , triterpene, amides and flavonoids , flavonoids, phenolics, triterpenes, tritepenoids, tannins, saponins and steroids  from the leaves of M. malabathricum extracted using various organic solvents extracts have been reviewed elsewhere . In term of the pharmacological activities, flavonoids exhibited antioxidant [55, 56], anti-inflammatory  and hepatoprotective [56, 57] activities; condensed tannins possess free radical scavenging and antioxidant, anti-inflammatory and hepatoprotective activities ; saponins exhibited hepatoprotective activity via modulation of its antioxidant  and anti-inflammatory activities . Based on all of the above reports, the MEMM-induced hepatoprotective activity is believed to involve synergistic action of, at least, flavonoids, saponins and condensed tannins. The HPLC analysis of MEMM at 366 nm demonstrated the presence of 4 major peaks with λmax falling in the region of 234.9, 254.3-367.2, 204.9-348.2 and 255.5-369.4 nm. These peaks may represent flavonoid-types of bioactive compounds (e.g. flavonoids subgroups are flavones, flavanones, flavonols, dihydroflavonols, and flavanonols) (Ali et al., 2010). The UV–vis spectra of flavonoids consist of two absorbance bands labeled as band A and band B . For flavones and flavonols, band A falls in the range of 310–350 nm and 350–385 nm while band B lies in the range of 250–290 nm, respectively. In the case of flavanones and dihydroflavonols, the wavelength of band A is often in the range of 300–330 nm while band B falls in the range of 277–295 nm. Furthermore, many polyphenols including flavonols demonstrated maximal absorbance at the wavelengths between 270 and 290 nm . Based on their respective wavelength in the chromatogram, we suggested that peak 2 and peak 4 might probably be the flavonoid-types of compounds. Further HPLC analysis in preliminary attempt to standardize the extract demonstrated that the MEMM contained quercetin, quercitrin and rutin.
The MEMM exhibited hepatoprotection against paracetamol-induced liver injury model, which could be, partly, attributed to its antioxidant activity and, linked to the presence and synergistic action of flavonoids, tannins and saponins. Further studies are warranted and are being planned to determine the possible hepatoprotective mechanism(s) involved and, to isolate and identified the responsible bioactive compounds.
This study was supported by the Science Fund Research Grant (Reference no. 06-01-04-SF1127) awarded by the Ministry of Science Technology and Innovation (MOSTI), Malaysia and the Research University Grant Scheme (Reference no. 04-02-12-2019RU) from the Universiti Putra Malaysia, Malaysia. The authors thanked the Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Malaysia for providing the facilities to carry out this study.
- Starr S, Hand H: Nursing care of chronic and acute liver failure. Nurs Stand. 2002, 16: 47-54.View ArticlePubMedGoogle Scholar
- Zakaria ZA, Rofiee MS, Somchit MN, Zuraini A, Sulaiman MR, Teh LK, Salleh MZ, Long K: Hepatoprotective activity of dried- and fermented-processed virgin coconut oil. Evid Based Complement Alternat Med. 2011, 2011: 142739-doi: 10.1155/2011/142739View ArticlePubMedPubMed CentralGoogle Scholar
- Arhoghro EM, Ekpo KE, Anosike EO, Ibeh GO: Effect of aqueous extract of bitter leaf (Vernonia amygdalina Del) on carbon tetrachloride (CCl4) induced liver damage in albino Wistar rat's. Eur J Sci Res. 2009, 26: 122-130.Google Scholar
- Pramyothin P, Ngamtin C, Poungshompoo S, Chaichantipyuth C: Hepatoprotective activity of Phyllanthus amarus Schum. et. Thonn. extract in ethanol treated rats: In vitro and in vivo studies. J Ethnopharmacol. 2007, 114: 169-173. 10.1016/j.jep.2007.07.037.View ArticlePubMedGoogle Scholar
- Jodynis-Liebert J, Matlawska I, Bylka W, Murias M: Protective effect of Aquilegia vulgaris on APAP-induced oxidative stress in rats. J Ethnopharmacol. 2005, 97: 351-358. 10.1016/j.jep.2004.11.027.View ArticlePubMedGoogle Scholar
- Zakaria ZA, Raden M, Nor RNS, Hanan Kumar G, Abdul Ghani ZDF, Sulaiman MR, Rathna Devi G, Mat Jais AM, Somchit MN, Fatimah CA: Antinociceptive, Anti-inflammatory and Anti-pyretic Properties of Melastoma malabathricum Leaves Aqueous Extract in Experimental Animals. Can J Physiol Pharm. 2006, 84: 1291-1299. 10.1139/y06-083.View ArticleGoogle Scholar
- Zakaria ZA, Abdul Hisam EE, Rofiee MS, Norhafizah M, Othman F, Hasiah AB, Vasudevan M: Methanol Extract of Bauhinia purpurea Leaf Possesses Antiulcer Activity. Med Princ Pract. 2012, 21: 476-482. 10.1159/000336593.View ArticlePubMedGoogle Scholar
- Mohd Joffry S, Yob NJ, Rofiee MS, Meor Mohd Affandi MMR, Othman F, Abdah MA, Mohd Desa MN, Suhaili Z, Zakaria ZA: Melastoma malabathricum (L.) Smith: A review of its ethnomedicinal, chemical and pharmacological uses. Evid Based Complement Alternat Med. 2012, 2012: 258434-doi: 10.1155/2012/258434PubMedGoogle Scholar
- Chattopadhyay RR: Possible mechanism of hepatoprotective activity of Azadirachta indica leaf extract. Part II. J Ethnopharmacol. 2003, 89: 217-219. 10.1016/j.jep.2003.08.006.View ArticlePubMedGoogle Scholar
- Sadasivan S, Latha PG, Sasikumar JM, Rajashekaran S, Shyamal S, Shine VJ: Hepatoprotective studies on Hedyotis corymbosa (L.) Lam. J Ethnopharmacol. 2006, 106: 245-249. 10.1016/j.jep.2006.01.002.View ArticlePubMedGoogle Scholar
- Dash DK, Yeligar VC, Nayak SS, Ghosh T, Rajalingam D, Sengupta P: Evaluation of hepatoprotective and antioxidant activity of Ichnocarpus frutescens (Linn.) R.Br. on paracetamol-induced hepatotoxicity in rats. Trop J Pharm Res. 2007, 6: 755-765.View ArticleGoogle Scholar
- Zakaria ZA, Rofiee MS, Mohamed AM, Teh LK, Salleh MZ: In vitro antiproliferative and antioxidant activities, and total phenolic contents of the extracts of Melastoma malabathricum leaves. J Acupunct Meridian Stud. 2011, 4: 248-256. 10.1016/j.jams.2011.09.016.View ArticlePubMedGoogle Scholar
- Singleton VL, Rossi JA: Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am J Enol Vitic. 1965, 16: 144-158.Google Scholar
- Blois MS: Antioxidant determinations by the use of a stable free radical. Nature. 1958, 18: 1199-1200.View ArticleGoogle Scholar
- Liu F, Ooi VE, Chang ST: Free radical scavenging activities of mushroom polysaccharide extracts. Life Sci. 1997, 60: 763-771. 10.1016/S0024-3205(97)00004-0.View ArticlePubMedGoogle Scholar
- Cao G, Prior RL: Measurement of oxygen radical absorbance capacity in biological samples. Meth Enzymol. 1999, 299: 50-62.View ArticlePubMedGoogle Scholar
- Yahya F, Ismail NA, Kamisan FH, Mamat SS, Shamsahal Din S, Wan Zainulddin WN, Zabidi Z, Mohtarrudin N, Suhaili Z, Zakaria ZA: Effect of aqueous extract of Melastoma malabathricum leaves against paracetamol- and CCl4-induced liver toxicity in rats. Afr J Pharm Pharmacol. 2012, 6: 2682-2685.Google Scholar
- El-Beshbishy HA, Mohamadin A, Nagy A, Abdel-Naim A: Amelioration of tamoxifen-induced liver injury in rats by grape seed extract, black seed extract and curcumin. Indian J Exp Biol. 2010, 48: 280-288.PubMedGoogle Scholar
- Kumar G, Banu GS, Pappa PV, Sundararajan MR, Pandian MR: Hepatoprotective activity of Trianthema portulacastrum L. against paracetamol and thioacetamide intoxication in albino rats. J Ethnopharmacol. 2004, 92: 37-40. 10.1016/j.jep.2003.12.009.View ArticlePubMedGoogle Scholar
- Akah PA, Odo CI: Hepatoprotective effect of the solvent fractions of the stem of Hoslundia opposita Vahl (Lamiaceae) against carbon tetrachloride- and paracetamol-induced liver damage in rats. Int J Green Pharm. 2010, 4: 54-58. 10.4103/0973-8258.62159.View ArticleGoogle Scholar
- Jollow DJ, Mitchell JR, Potter WZ, Davis DC, Gillette JR, Brodie BB: Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharm Exp Ther. 1973, 187: 195-202.Google Scholar
- Potter WZ, Davis DC, Mitchell JR, Jollow DJ, Gillette JR, Brodie BB: A cetaminophen-induced hepatic necrosis. III. Cytochrome P-450-mediated covalent binding in vitro. J Pharm Exp Ther. 1973, 187: 203-210.Google Scholar
- Ajay KG, Neelam M: Hepatoprotective activity of aqueous ethanolic extract of Chamomile capitula in paracetamol intoxicated albino rats. Am J Pharmacol Toxicol. 2006, 1: 17-20.View ArticleGoogle Scholar
- Somchit MN, Zuraini A, Bustamam AA, Somchit N, Sulaiman MR, Noratunlina R: Protective activity of turmeric (Curcuma longa) in paracetamol-induced hepatotoxicity in rats. Int J Pharmacol. 2005, 1: 252-256.View ArticleGoogle Scholar
- Yanpallewar SU, Sen S, Tapas S, Kumar M, Raju SS, Acharya SB: Effect of Azadirachta indica on paracetamol induced hepatic damage in albino rats. Phytomedicine. 2002, 10: 391-396.View ArticleGoogle Scholar
- Shenoy KA, Somayaji SN, Bairy KL: Evaluation of hepatoprotective activity of Ginkgo biloba against in rats. Indian J Pharmacol. 2002, 46: 167-174.Google Scholar
- Amacher DE: Serum transaminase elevations as indicators of hepatic injury following the administration of drugs. Regul Toxicol Pharmacol. 1998, 27: 119-130. 10.1006/rtph.1998.1201.View ArticlePubMedGoogle Scholar
- Uma N, Fakurazi S, Hairuszah I: Moringa oleifera enhances liver antioxidant status via elevation of antioxidant enzymes activity and counteracts paracetamol-induced hepatotoxicity. Malays J Nutr. 2010, 16: 293-307.PubMedGoogle Scholar
- Shimoda H, Seki E, Aitani M: Inhibitory effect of green coffee bean extract on fat accumulation and body weight gain in mice. BMC Complement Altern Med. 2006, 6: 9-10.1186/1472-6882-6-9. doi: 10.1186/1472-6882-6-9View ArticlePubMedPubMed CentralGoogle Scholar
- Auvichayapat P, Prapochanung M, Tunkamnerdthai O, Sripanidkulchai B, Auyichayapat N, Thinkhamrop B, Kunhasura S, Wongpratoom S, Sinawat S, Hongprapas P: Effectiveness of green tea on weight reduction in obese Thais: A randomized, controlled trial. Physiol Behav. 2008, 93: 486-491. 10.1016/j.physbeh.2007.10.009.View ArticlePubMedGoogle Scholar
- Yang J, Li Y, Wang F, Wu CF: Hepatoprotective effects of apple polyphenols on CCl4-induced acute liver damage in mice. J Agric Food Chem. 2010, 58: 6525-6531. 10.1021/jf903070a.View ArticlePubMedGoogle Scholar
- Pichiah PB, Moon HJ, Park JE, Moon YJ, Cha YS: Ethanolic extract of seabuckthorn (Hippophae rhamnoides L.) prevents high-fat diet-induced obesity in mice through down-regulation of adipogenic and lipogenic gene expression. Nutr Res. 2012, 32: 856-864. 10.1016/j.nutres.2012.09.015.View ArticlePubMedGoogle Scholar
- Van Gaal LF, Wauters MA, De Leeuw IH: The beneficial effects of modest weight loss on cardiovascular risk factors. Int J Obes Relat Metab Disord. 1997, 21: S5-S9.PubMedGoogle Scholar
- Michael SL, Pumfod NR, Mayeux PR, Niesman MR, Hinson JA: Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species. Hepatology. 1999, 30: 186-195. 10.1002/hep.510300104.View ArticlePubMedGoogle Scholar
- Minamide Y, Horie T, Tomaru A, Awasu S: Spontaneous chemiluminescence production, lipid peroxidation and covalent binding in rat hepatocytes exposed to acetaminophen. J Pharm Sci. 1998, 87: 640-646. 10.1021/js9701014.View ArticlePubMedGoogle Scholar
- Mirochnitchenko O, Weisbrot-Lefkowitz M, Reuhl K, Chen L, Yang C, Inouye M: Acetaminophen toxicity. Opposite effects of two forms of glutathione peroxidase. J Biol Chem. 1999, 274: 10349-10355. 10.1074/jbc.274.15.10349.View ArticlePubMedGoogle Scholar
- Gupta AK, Chitme H, Dass SK, Misra N: Hepatoprotective activity of Rauwolfia serpentina rhizome in paracetamol intoxicated rats. J Pharmacol Toxicol. 2006, 1: 82-88.View ArticleGoogle Scholar
- Carolina H, Sergio A, Italo C, Tania V, Manuel A, Lorena C, Ricardo S, Hernán S: Determination of antioxidant capacity, total phenolic content and mineral composition of different fruit tissue of five apple cultivars grown in Chile. Chil J Agr Res. 2010, 70: 523-536. 10.4067/S0718-58392010000400001.View ArticleGoogle Scholar
- Qader SW, Abdulla MA, Chua LS, Najim N, Zain MM, Hamdan S: Antioxidant, total phenolic content and cytotoxicity evaluation of selected Malaysian plants. Molecules. 2011, 16: 3433-3443. 10.3390/molecules16043433.View ArticlePubMedGoogle Scholar
- Molina MF, Sanchez-Reus I, Iglesias I, Benedi J: Quercetin, a flavonoid antioxidant, prevents and protects against ethanol-induced oxidative stress in mouse liver. Biol Pharm Bull. 2003, 26: 1398-1402. 10.1248/bpb.26.1398.View ArticlePubMedGoogle Scholar
- Kamalakkannan N, Prince PS: Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic Wistar rats. Basic Clin Pharmacol Toxicol. 2006, 98: 97-103. 10.1111/j.1742-7843.2006.pto_241.x.View ArticlePubMedGoogle Scholar
- Hong CO, Lee HA, Rhee CH, Choung SY, Lee KW: Separation of the antioxidant compound quercitrin from Lindera obtusiloba Blume and its antimelanogenic effect on B16F10 melanoma cells. Biosci Biotechnol Biochem. 2013, 77: 58-64. 10.1271/bbb.120562.View ArticlePubMedGoogle Scholar
- Luster MI, Simeonova PP, Gallucci RM, Matheson JM, Yucesoy B: Immunotoxicology: role of inflammation in chemical-induced hepatotoxicity. Int J Immunopharmacol. 2000, 22: 1143-1147. 10.1016/S0192-0561(00)00073-4.View ArticlePubMedGoogle Scholar
- Zakaria ZA, Raden Mohd Nor RNS, Abdul Ghani ZDF, Hanan Kumar G, Sulaiman MR, Fatimah CA: Antinociceptive and anti-inflammatory properties of Melastoma malabathricum leaves chloroform extract in experimental animals. J Pharmacol Toxicol. 2006, 1: 337-345.View ArticleGoogle Scholar
- Rotelli AE, Guardia T, Juárez AO, de la Rocha NE, Pelzer LE: Comparative study of flavonoids in experimental models of inflammation. Pharmacol Res. 2003, 48: 601-606. 10.1016/S1043-6618(03)00225-1.View ArticlePubMedGoogle Scholar
- Comalada M, Camuesco D, Sierra S, Ballester I, Xaus J, Gálvez J, Zarzuelo A: In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway. Eur J Immunol. 2005, 35: 584-592. 10.1002/eji.200425778.View ArticlePubMedGoogle Scholar
- Selloum L, Bouriche H, Tigrine C, Boudoukha C: Anti-inflammatory effect of rutin on rat paw oedema, and on neutrophils chemotaxis and degranulation. Exp Toxicol Pathol. 2003, 54: 313-318. 10.1078/0940-2993-00260.View ArticlePubMedGoogle Scholar
- Yoshida T, Nakata F, Hosotani K, Nitta A, Okuda T: Dimeric hydrolysable tannins from Melastoma malabathricum. Phytochemistry. 1992, 31: 2829-2833. 10.1016/0031-9422(92)83641-B.View ArticleGoogle Scholar
- Nuresti S, Baek SH, Asari A: Chemical components of Melastoma malabathricum. ACGC Chem Res Commun. 2003, 16: 28-33.Google Scholar
- Ali DMH, Wong KC, Boey LP: Triterpenoids, glycolipids and flavonoids of Melastoma malabathricum: Isolation, spectrometric characterization and antibacterial activity. 2010, Germany: VDM Verlag, 1-228.Google Scholar
- Koay SS: PhD. Thesis. Establishment of cell suspension culture of Melastoma malabathricum L. for the production of anthocyanin. 2008, Pulau Pinang, Malaysia: UniversitiSains MalaysiaGoogle Scholar
- Nazlina I, Norha S, Noor Zarina AW, Ahmad IB: Cytotoxicity and antiviral activity of Melastoma malabathricum extracts. Malays J Appl Biol. 2008, 37: 53-55.Google Scholar
- Susanti D, Sirat HM, Ahmad F, Mat Ali R: Bioactive constituents from the leaves of Melastoma malabathricum L. Jurnal Ilmiah Farmasi. 2008, 5: 1-8.Google Scholar
- Faravani M: PhD thesis. The population biology of Straits Rhododendron (Melastoma malabathricum L.). 2009, Kuala Lumpur: University of MalayaGoogle Scholar
- Ferreira JFS, Luthria DL, Sasaki T, Heyerick A: Flavonoids from Artemisia annuaas antioxidants and their potential synergism with Artemisinin against malaria and cancer. Molecules. 2010, 15: 3135-3170. 10.3390/molecules15053135.View ArticlePubMedGoogle Scholar
- Tapas AR, Sakarkar DM, Kakde RB: Flavonoids as nutraceuticals: a review. Trop J Pharm Res. 2008, 7: 1089-1099.View ArticleGoogle Scholar
- Sandhar HK, Kumar B, Prasher S, Tiwari P, Salhan M, Sharma PA: Review of phytochemistry and pharmacology of flavonoids. Int Pharm Sci. 2011, 1: 24-41.Google Scholar
- Pithayanukul P, Nithitanakool S, Bavovada R: Hepatoprotective potential of extracts from seeds of areca catechu and nutgalls of Quercus infectoria. Molecules. 2009, 14: 4987-5000. 10.3390/molecules14124987.View ArticlePubMedGoogle Scholar
- Elekofehinti OO, Adanlawo IG, Komolafe K, Ejelonu OC: Saponins from solanum anguivi fruits exhibit antioxidant potential in wistar rats. Ann Biol Res. 2012, 3: 3212-3217.Google Scholar
- Akkol EK, Tatli II, Akdemir ZS: Antinociceptive and anti-inflammatory effects of Saponin and Iridoid Glycosides from Verbascum pterocalycinum var. mutense Hub.-Mor. Z Naturforsch. 2007, 62: 813-820.Google Scholar
- Tsimogiannis D, Samiotaki M, Panayotou G, Oreopoulou V: Characterization of flavonoid subgroups and hydroxy substitution by HPLC-MS/MS. Molecules. 2007, 12: 593-606. 10.3390/12030593.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/13/326/prepub
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.